# A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris

> **NCT03780166** · PHASE2 · WITHDRAWN · sponsor: **Incyte Corporation**

## Conditions studied

- Pemphigus Vulgaris

## Interventions

- **DRUG:** Parsaclisib

## Key facts

- **NCT ID:** NCT03780166
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-03
- **Primary completion:** 2020-11
- **Final completion:** 2020-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was withdrawn due to insufficient interest in study participation due to recent approval in this rare condition.
- **Last updated:** 2019-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03780166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03780166, "A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03780166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*